Loading…
* Free cash flow = OCF − net investing outflow (the filings carry no standalone capex line).
Operates in Healthcare Services — General medicine - private practice. Per the activity note to the FY2024 annual report, the company provides general medical practice and healthcare services.
| Ratio | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Margins | |||||
| Gross Margin | 13.5% | 30.3% | 26.0% | 28.8% | 29.0% |
| EBITDA Margin | -101.0% | -1.6% | -23.2% | -17.8% | -12.8% |
| EBITDAR | -1,152 | -98 | -1,536 | -1,380 | -1,475 |
| EBITDAR Margin | -101.0% | -1.6% | -23.2% | -17.8% | -12.8% |
| EBIT Margin | -117.6% | -1.6% | -23.2% | -20.1% | -14.6% |
| Net Profit Margin | -138.1% | -21.4% | -36.3% | -20.8% | -15.1% |
| Operating Expense % of Sales | 114.5% | 31.9% | 49.2% | 46.5% | 41.8% |
| Returns | |||||
| Return on Assets (ROA) | -89.1% | -13.5% | -37.1% | -25.8% | -27.6% |
| Return on Equity (ROE) | N/A | N/A | N/A | N/A | N/A |
| ROIC [EBIT / Invested Capital] | -224.8% | -4.4% | -34.3% | -43.1% | -49.4% |
| Leverage & debt balances | |||||
| Debt-to-Assets | 166.5% | 53.1% | 136.9% | 156.5% | 173.5% |
| Debt-to-Equity | -1.26x | -1.86x | -2.20x | -1.77x | -1.50x |
| Debt-to-EBITDA | N/A | N/A | N/A | N/A | N/A |
| Equity-to-Assets | -132.5% | -28.6% | -62.3% | -88.6% | -116.0% |
| Net Debt | 2,940 | 4,956 | 8,516 | 9,174 | 10,712 |
| Cash & Equivalents | 3 | 126 | 360 | 648 | 222 |
| Total Debt | 2,943 | 5,081 | 8,875 | 9,823 | 10,934 |
| Liquidity & working capital | |||||
| Current Ratio | 0.11x | 0.49x | 0.26x | 0.61x | 0.90x |
| Quick Ratio | 0.05x | 0.49x | 0.26x | 0.61x | 0.90x |
| Cash Ratio | 0.00x | 0.03x | 0.11x | 0.26x | 0.07x |
| Total Current Assets | 205 | 2,010 | 834 | 1,527 | 2,915 |
| Total Current Liabilities | 1,843 | 4,101 | 3,269 | 2,516 | 3,240 |
| Inventory | 117 | N/A | N/A | N/A | N/A |
| Trade Receivables | 85 | 1,767 | 192 | 491 | 728 |
| Trade Payables | N/A | N/A | 1,123 | 803 | 1,196 |
| Net Working Capital | -1,638 | -2,091 | -2,435 | -989 | -324 |
| Net Working Capital % of Revenue | -143.5% | -34.6% | -36.8% | -12.7% | -2.8% |
| Trade Working Capital | 202 | 1,767 | -932 | -312 | -468 |
| Trade Working Capital % of Revenue | 17.7% | 29.2% | -14.1% | -4.0% | -4.1% |
| Change in Trade Working Capital | N/A | 1,565 | -2,699 | 619 | -156 |
| Turnover & efficiency | |||||
| Inventory Turnover | 8.40x | N/A | N/A | N/A | N/A |
| Days Inventory Outstanding (DIO) | 43.4 | N/A | N/A | N/A | N/A |
| Receivables Turnover | 13.44x | 3.42x | 34.56x | 15.83x | 15.82x |
| Days Sales Outstanding (DSO) | 27.2 | 106.6 | 10.6 | 23.1 | 23.1 |
| Payables Turnover | N/A | N/A | 4.36x | 6.89x | 6.84x |
| Days Payable Outstanding (DPO) | N/A | N/A | 83.7 | 53.0 | 53.4 |
| Cash Conversion Cycle | 70.6 days | 106.6 days | -73.1 days | -29.9 days | -30.3 days |
| Asset Turnover | 0.65x | 0.63x | 1.02x | 1.24x | 1.83x |
| Cash flow & dividends | |||||
| Operating Cash Flow | -892 | -1,283 | 651 | 26 | 579 |
| Free Cash Flow (OCF − Capex proxy) | -1,052 | -1,446 | 546 | -97 | 87 |
| Cash Conversion (OCF / EBITDA) | N/A | N/A | N/A | N/A | N/A |
| Dividends Declared | N/A | N/A | N/A | N/A | N/A |
| Dividend Payout Ratio | N/A | N/A | N/A | N/A | N/A |
Money rows — EBITDAR, net debt, cash, total debt, operating and free cash flow, dividends declared — are in GEL, thousands. Margins, returns and payout are percentages; turnover and leverage are multiples; DIO/DSO/DPO are days. Hover a metric name for its definition.
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set. Open this set in Compare →